Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5317-5324

  Aharinejad, Seyedhossein ^a   Abraham, Dietmar ^a   Paulus, Patrick ^a   Abri, Hojatollah ^a   Hofmann, Michael ^a   Grossschmidt, Karl ^a   Schiller, Romana ^a   Stanley, E Richard ^b   Hofbauer, Reinhold ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR 1 ANTISENSE OLIGODEOXYNUCLEOTIDE; COLONY STIMULATING FACTOR RECEPTOR; GELATINASE A; INTERSTITIAL COLLAGENASE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GRAFT; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CELL INVASION; COLON CANCER; COLON CARCINOMA; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO CELL; ENZYME MECHANISM; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOREGULATION; INHIBITION KINETICS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; START CODON; TUMOR XENOGRAFT;

ANIMALS; CELL DIVISION; COLONIC NEOPLASMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0037105725     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. The multistep nature of cancer development
2. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis
3. Proteases in invasion: Matrix metalloproteinases
4. Metastic potential correlates with enzymatic degradation of basement membrane collagen
5. ECM cell surface proteolysis: Regulating cellular ecology
6. ECM signaling: Orchestrating cell behaviour and misbehaviour
7. Mutations in the SMAD4/DPC4 gene in juvenile polyposis
8. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis
9. Radial scars in benign breast-biopsy specimens and the risk of breast cancer
10. Matrix metalloproteinases and the development of cancer
11. The origin and function of tumor-associated macrophages
12. How does extracellular matrix control capillary morphogenesis?
13. Activated macrophages induce vascular proliferation
14. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases
15. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
16. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1
17. Additive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells
18. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
19. op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis
20. CSF-1-a mononuclear phagocyte lineage-specific hemopoietic growth factor
21. CSF-1 treatment promotes angiogenesis in the metaphysis of osteopetrotic (toothless) rats
22. The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients
23. Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms
24. Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1
25. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells
26. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
27. Chemosensitisation of malignant melanoma by BCL2 antisense therapy
28. Efficient carboplatin single therapy in a mouse model of human testicular nonseminomatous germ cell tumor
29. Effect of tumor size on the enhancement by gamma interferon of the localization of radiolabeled F(ab′)2 fragments of anti-intercellular adhesion molecule-1 monoclonal antibodies in human colon carcinoma cells grafted in nude mice
30. Selective down-regulation of VEGF-A(165). VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy
31. Angiogenesis, microvascular architecture, microhemodynamicsand interstitial fluid pressure during early growth of human adenocarcinoma LSI74T in SCID mice
32. The macrophage colony stimulating factor. CSF-1
33. Regulation of colony-stimulating factor 1 during pregnancy
34. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse
35. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
36. Tumor targeting with a selective gelatinase inhibitor
37. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase
38. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
39. Colony-stimulating factor-1 induces rapid behavioural responses in the mouse macrophage cell line. BAC1.2F5
40. Tumor induction of VEGF promoter activity in stromal cells
41. Angiogenesis in cancer and other diseases
42. Vascular-specific growth factors and blood vessel formation
43. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo
44. Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) receptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration through phosphatidylinositol 3-kinase-dependent pathways
45. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical?
46. The experimental use of antisense oligonucleotides: A guide for the perplexed
47. Translating genomics information into therapeutics: A key role for oligonucleotides
48. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells
49. The macrophage colony stimulating factor CSF-1, an auto- and paracrine tumor cytokine is also a circulating "tumor marker" in patients with ovarian, endometrial and pulmonary neoplasms
50. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis